Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Tyler Jacks is Director at Thermo Fisher Scientific. OQRO lists 2 transactions filed with the SEC under this name, the latest on May 22, 2026, each linked to the official Form 4.
Director
Disclosures on record
2
Companies involved
2
Tyler Jacks bought shares on the open market in 2009, and has not bought since 2009 across 2 companies. Sales in 3 of the 18 years since 2009.
Tyler Jacks reported 1 open-market purchase and 5 sales since 2009; purchases in 2009.
| Year | Bought | Sold |
|---|---|---|
| 2018 | — | $5.33M3×3 trades |
| 2015 | — | $1.95M1×1 trade |
| 2012 | — | $154K1×1 trade |
| 2009 | $46K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
May 20, 2026499disclosed May 22
DetailsOfficial recordAmgenAMGN
May 19, 2026665disclosed May 21
DetailsOfficial recordAs of the latest filing on , Tyler Jacks reported holding 18,284 shares of Amgen (AMGN), worth about $8.12M at the last close of $444 (Nov 18, 2026). Holdings are also on file at Thermo Fisher Scientific (TMO); together they are worth about $14.7M.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Amgen AMGN | 18,284 | 18K direct | $444 | $8.12M | May 19, 2026 |
| Thermo Fisher Scientific TMO | 9,462 | 9,462 direct | $693 | $6.55M | May 20, 2026 |
Is this Tyler Jacks’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Tyler Jacks reported 1 open-market purchase and 4 sales here, 2009 to 2018.
Tyler Jacks reported 0 open-market purchases and 1 sale here, 2018.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated May 19, 2026, Tyler Jacks reported holding 18,284 shares of Amgen (AMGN). At the last close of $444 on Nov 18, 2026, that is about $8.12M. This is the stake disclosed in filings, not a net worth.
No public filing gives Tyler Jacks's net worth. What SEC Form 4 shows is the stock stake: 18,284 shares of Amgen (AMGN), about $8.12M at the last close, plus holdings in 1 other company, about $14.7M in all. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
Tyler Jacks bought shares on the open market in 2009, and has not bought since 2009 across 2 companies. Sales in 3 of the 18 years since 2009.
In SEC filings since 2009: the latest open-market purchase is from 2009; the latest open-market sale is from 2018.
2 companies: Thermo Fisher Scientific (TMO, 2009–2018), Amgen (AMGN, 2018).